Clinical Study for Itolizumab in Lupus Nephritis Initiated in India Post DCGI Approval.
23-Dec-2021
Download PDF
Biocon
Clinical Study for Itolizumab in Lupus Nephritis Initiated in India Post DCGI Approval.
Mutual Fund Insight turns 24! 🎉 Get 2 FREE anniversary guides: The Right SIP + The Big Funds